- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Sustainable Track Record
Pakistani Pharmaceuticals & Biotech Sustainable Track Record
Results
5
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
5 companies
AGP
Market Cap: PK₨52.5b
Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.
AGP
PK₨187.33
7D
1.9%
1Y
17.4%
Hoechst Pakistan
Market Cap: PK₨41.1b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,257.02
7D
1.5%
1Y
59.0%
GlaxoSmithKline Pakistan
Market Cap: PK₨127.2b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨399.44
7D
3.4%
1Y
6.8%
Macter International
Market Cap: PK₨15.6b
A contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan.
MACTER
PK₨341.01
7D
-0.7%
1Y
19.3%
Highnoon Laboratories
Market Cap: PK₨57.2b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,080.52
7D
-2.5%
1Y
16.1%